Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 05/22

Trade details

Type: Insider sale
Amount: $6,054,000
Shares · price: 200,000 sh · $30.27 a share
Held after: 1,613,063 sh
Stock: Roivant Sciences ROIV
Person: Eric VenkerPresident & Immunovant CEO
Trade date: 26/05/22
Filed: 26/05/22
Days to filing: 0 days

Sold 11.0% of holdings

Share of holding sold: 11.0%

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 04/22~06/21

Eric Venker's recent trades

Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$1.5M
46,234 sh
$1.5M
Filed 06/26
Traded 06/24